| [1] |
Liu S W, Chang X D, Liu X F, et al. Effects of pretreatments on anthocyanin composition, phenolics contents and antioxidant capacities during fermentation of hawthorn(Crataegus pinnatifida) drink[J]. Food Chem, 2016, 212: 87- 95. DOI: 10.1016/j.foodchem.2016.05.146.
|
| [2] |
Li C J, Chen Y E, Yuan X, et al. Vitexin ameliorates chronic stress plub high fat diet-induced nonalcoholic fatty liver disease by inhibiting inflammation[J]. Eur J Pharmacol, 2020, 882: 173264. DOI: 10.1016/j.ejphar.2020.173264.
|
| [3] |
Li Y H, Ye M H, He Q J, et al. Novel dual AMPK/NRF2 activation by leucocyanidin from Hawthorn(Crataegus) for mitochondria repair-Targeted therapy of hepatic steatosis[J]. Phytomedicine, 2026, 150: 157614. DOI: 10.1016/j.phymed.2025.157614.
|
| [4] |
Zhang Mingfa, Shen Yaqin. Research advances on effects of ursolic acid and oleanolic acid against hepatic steatosis and fibrosis[J]. Drug Eval Res, 2017, 40( 2): 270- 278. DOI: 10.7501/j.issn.1674-6376.2017.02.028.
张明发, 沈雅琴. 熊果酸和齐墩果酸抗肝脂肪变和纤维化作用研究进展[J]. 药物评价研究, 2017, 40( 2): 270- 278. DOI: 10.7501/j.issn.1674-6376.2017.02.028.
|
| [5] |
Sun Y, Meng X W, Chen M J, et al. Isolation, structural properties and bioactivities of polysaccharides from Crataegus pinnatifida[J]. J Ethnopharmacol, 2024, 323: 117688. DOI: 10.1016/j.jep.2023.117688.
|
| [6] |
Eghlima G, Aghamir F, Mohammadi M, et al. Bioactive compounds and antimicrobial activities in Iranian Crataegus persica ecotypes for potential food and medicinal uses[J]. Food Sci Nutr, 2025, 13( 1): e4748. DOI: 10.1002/fsn3.4748.
|
| [7] |
Zheng L P, Lu Z H, Ma Y R, et al. Hawthorn total flavonoids ameliorate hyperlipidemia through AMPK/SREBP1-c and PPARα/PGC-1α/CPT-1A pathway activation and gut microbiota modulation[J]. J Sci Food Agric, 2025, 105( 8): 4326- 4337. DOI: 10.1002/jsfa.14188.
|
| [8] |
Gao Z Q, Xie M J, Zhou R Y, et al. Ameliorative effects of Monascus-fermented hawthorn extract on a high-fat diet-induced rat model of non-alcoholic fatty liver disease[J]. Heliyon, 2024, 10( 18): e37354. DOI: 10.1016/j.heliyon.2024.e37354.
|
| [9] |
Yang H, Yang T T, Heng C, et al. Quercetin improves nonalcoholic fatty liver by ameliorating inflammation, oxidative stress, and lipid metabolism in db/db mice[J]. Phytother Res, 2019, 33( 12): 3140- 3152. DOI: 10.1002/ptr.6486.
|
| [10] |
Yu Q H, Chen X J, Sun X, et al. Pectic oligogalacturonide facilitates the synthesis and activation of adiponectin to improve hepatic lipid oxidation[J]. Mol Nutr Food Res, 2021, 65( 20): e2100167. DOI: 10.1002/mnfr.202100167.
|
| [11] |
Gheitasi I, Savari F, Akbari G, et al. Molecular mechanisms of hawthorn extracts in multiple organs disorders in underlying of diabetes: A review[J]. Int J Endocrinol, 2022, 2022: 2002768. DOI: 10.1155/2022/2002768.
|
| [12] |
Liu S W, Yu J C, Fu M F, et al. Regulatory effects of hawthorn polyphenols on hyperglycemic, inflammatory, insulin resistance responses, and alleviation of aortic injury in type 2 diabetic rats[J]. Food Res Int, 2021, 142: 110239. DOI: 10.1016/j.foodres.2021.110239.
|
| [13] |
Gu W J, Wang R Q, Cai Z W, et al. Hawthorn total flavonoids ameliorate ambient fine particulate matter-induced insulin resistance and metabolic abnormalities of lipids in mice[J]. Ecotoxicol Environ Saf, 2023, 249: 114456. DOI: 10.1016/j.ecoenv.2022.114456.
|
| [14] |
Wang X X, Li X, Li L Y, et al. Hawthorn fruit extract ameliorates H2O2-induced oxidative damage in neuronal PC12 cells and prolongs the lifespan of Caenorhabditis elegans via the IIS signaling pathway[J]. Food Funct, 2022, 13( 20): 10680- 10694.
|
| [15] |
Hamza A A, Lashin F M, Gamel M, et al. Hawthorn herbal preparation from Crataegus oxyacantha attenuates in vivo carbon tetrachloride-induced hepatic fibrosis via modulating oxidative stress and inflammation[J]. Antioxidants(Basel), 2020, 9( 12): 1173. DOI: 10.3390/antiox9121173.
|
| [16] |
Mousa A M, Allemailem K S. Could hawthorn have a cardioprotective impact against obesity-induced cardiac injury in rats via antioxidant, hypolipidemic, anti-inflammatory, antiapoptotic, and antifibrotic properties?[J]. Tissue Cell, 2025, 93: 102673. DOI: 10.1016/j.tice.2024.102673.
|
| [17] |
Yue Caixia, Chen Lei, Wang Wenkui, et al. Maslinic acid protects against LPS-induced inflammatory response in RAW264.7 cells by regulating phosphorylation of STAT3[J]. Food Mach, 2021, 37( 6): 36- 42. DOI: 10.13652/j.issn.1003-5788.2021.06.007.
岳彩霞, 陈磊, 王文魁, 等. 山楂酸调控STAT3磷酸化保护LPS致RAW264.7细胞炎症反应的研究[J]. 食品与机械, 2021, 37( 6): 36- 42. DOI: 10.13652/j.issn.1003-5788.2021.06.007.
|
| [18] |
Liu S, Fang Y, Yu J, et al. Hawthorn polyphenols reduce high glucose-induced inflammation and apoptosis in ARPE-19 cells by regulating miR-34a/SIRT1 to reduce acetylation[J]. J Food Biochem, 2021, 45( 2): e13623. DOI: 10.1111/jfbc.13623.
|
| [19] |
Chen Xing. Extraction, purification, characterization and antioxidant activity of polysaccharides from Crataegus pinnatifida bunge[D]. Huai’an: Huai’an University, 2020. DOI: 10.27944/d.cnki.ghygy.2020.000019.
陈星. 山楂多糖的提取纯化、表征及其体外抗氧化活性研究[D]. 淮安: 淮阴工学院, 2020. DOI: 10.27944/d.cnki.ghygy.2020.000019.
|
| [20] |
Chang Jiahan, Cai Yujie, Hou Yixin, et al. Regulatory role of macrophage glycolysis in metabolic dysfunction-associated fatty liver disease[J]. J Clin Hepatol, 2025, 41( 10): 2130- 2135. DOI: 10.12449/JCH251025.
常嘉涵, 蔡玉洁, 侯艺鑫, 等. 巨噬细胞糖酵解在代谢相关脂肪性肝病中的调控作用[J]. 临床肝胆病杂志, 2025, 41( 10): 2130- 2135. DOI: 10.12449/JCH251025.
|
| [21] |
Zhou Bicong, Yang Ying. Mechanism of Shanzha(hawthorn)extract in regulating dyslipidemia by affecting T cells through NETs[J]. Chin Arch Tradit Chin Med, 2026, 44( 3): 55- 59. DOI: 10.13193/j.issn.1673-7717.2026.03.010.
周碧聪, 杨莺. 山楂提取物通过NETs影响T细胞调控血脂异常的作用机制研究[J]. 中华中医药学刊, 2026, 44( 3): 55- 59. DOI: 10.13193/j.issn.1673-7717.2026.03.010.
|
| [22] |
Huang Haoxiao, Yang Ying, Liu Ning. Effects of Shanzha(crataegi fructus) extract on Th1 and Th2 cell subsets in dyslipidemic mice based on modulation of TBX21 and GATA-3 factors[J]. Chin Arch Tradit Chin Med, 2024, 42( 12): 40- 46. DOI: 10.13193/j.issn.1673-7717.2024.12.009.
黄昊枭, 杨莺, 刘宁. 山楂提取物基于调控TBX21、GATA-3因子对血脂异常小鼠Th1、Th2细胞亚群的影响[J]. 中华中医药学刊, 2024, 42( 12): 40- 46. DOI: 10.13193/j.issn.1673-7717.2024.12.009.
|
| [23] |
Sun Hui, Fan Manlu, Lu Huan, et al. Research progress in the regulation of gut-liver axis microecology with traditional Chinese medicine in the treatment of metabolism-associated fatty liver disease[J]. J Changchun Univ Chin Med, 2026, 42( 3): 373- 378. DOI: 10.13463/j.cnki.cczyy.2026.03.023.
孙慧, 樊曼璐, 卢欢, 等. 中医药调控肠肝轴微生态治疗代谢相关脂肪性肝病研究进展[J]. 长春中医药大学学报, 2026, 42( 3): 373- 378. DOI: 10.13463/j.cnki.cczyy.2026.03.023.
|
| [24] |
Yang Xue, Zhang Xu, Xian Jin, et al. Mechanism of action of traditional Chinese medicine in treatment of nonalcoholic fatty liver disease based on intestinal microecology[J]. J Clin Hepatol, 2024, 40( 4): 804- 809. DOI: 10.12449/JCH240426.
杨雪, 张旭, 仙晋, 等. 基于肠道微生态探讨中医药治疗非酒精性脂肪性肝病的作用机制[J]. 临床肝胆病杂志, 2024, 40( 4): 804- 809. DOI: 10.12449/JCH240426.
|
| [25] |
Zhou Y, Wang M Y, Wang Z C, et al. Polysaccharides from hawthorn fruit alleviate high-fat diet-induced NAFLD in mice by improving gut microbiota dysbiosis and hepatic metabolic disorder[J]. Phytomedicine, 2025, 139: 156458. DOI: 10.1016/j.phymed.2025.156458.
|
| [26] |
Li T, Chen J B, Xu Y C, et al. Hawthorn pectin alleviates DSS-induced colitis in mice by ameliorating intestinal barrier function and modulating gut microbiota[J]. J Agric Food Chem, 2025, 73( 10): 5872- 5885. DOI: 10.1021/acs.jafc.4c07965.
|
| [27] |
Li J Y, Hu W J, Li C J, et al. Recent advances in hawthorn(Crataegus L.) polysaccharides for prevention and treatment of non-alcoholic fatty liver disease(NAFLD): A review[J]. Int J Biol Macromol, 2026, 336: 149403. DOI: 10.1016/j.ijbiomac.2025.149403.
|
| [28] |
Liu G C, Cui Z, Gao X Y, et al. Corosolic acid ameliorates non-alcoholic steatohepatitis induced by high-fat diet and carbon tetrachloride by regulating TGF-β1/Smad2, NF-κB, and AMPK signaling pathways[J]. Phytother Res, 2021, 35( 9): 5214- 5226. DOI: 10.1002/ptr.7195.
|
| [29] |
Chen X Y, Wang Y F, Wan J, et al. Quercetin alleviates liver fibrosis via regulating glycolysis of liver sinusoidal endothelial cells and neutrophil infiltration[J]. Biomol Biomed, 2024, 24( 6): 1806- 1815. DOI: 10.17305/bb.2024.10530.
|
| [30] |
Zhu Lixia, Wang Lisheng, Zhang Yingfeng. Study on serum lipid level, content of SOD and MDA of Salvia miltiorrhizae total Salvianolic acid and hawthorn flavonoids compatibility in hyperlipidemia rats[J]. China Med Her, 2014, 11( 20): 9- 12.
朱黎霞, 王利胜, 张英丰. 丹参总酚酸、山楂总黄酮组分配伍对高脂血症大鼠血脂、超氧化物歧化酶及丙二醛的影响[J]. 中国医药导报, 2014, 11( 20): 9- 12.
|
| [31] |
Wang H, Wang H, Zhang J, et al. Molecular mechanism of crataegi folium and Alisma Rhizoma in the treatment of dyslipidemia based on network pharmacology and molecular docking[J]. Evid Based Complementary Altern Med, 2022, 2022( 1): 4891370. DOI: 10.1155/2022/4891370.
|
| [32] |
Gao Hongru, Lu Bingjiu. Professor Lu bingjiu’s experience in treatment of fatty liver by hawthorn and rhizoma alismatis[J]. J Shaanxi Univ Chin Med, 2016, 39( 2): 23- 24, 102. DOI: 10.13424/j.cnki.jsctcm.2016.02.008.
高红如, 卢秉久. 卢秉久教授配伍运用山楂与泽泻治疗脂肪肝经验[J]. 陕西中医药大学学报, 2016, 39( 2): 23- 24, 102. DOI: 10.13424/j.cnki.jsctcm.2016.02.008.
|
| [33] |
Huang Y L, Chow C J, Tsai Y H. Composition, characteristics, and in-vitro physiological effects of the water-soluble polysaccharides from Cassia seed[J]. Food Chem, 2012, 134( 4): 1967- 1972. DOI: 10.1016/j.foodchem.2012.03.127.
|
| [34] |
Li Y J, Wang P Q, Yang H, et al. In vivo identification of bioactive components of Poria cocos for adjusting mitochondria against metabolic dysfunction-associated fatty liver disease[J]. Heliyon, 2024, 10( 16): e35645. DOI: 10.1016/j.heliyon.2024.e35645.
|